Walleye Capital LLC Avidity Biosciences, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.3 - $11.35 $698,575 - $1.26 Million	110,885 Added 898.95%	123,220 $786,000
Q2 2023 Aug 14, 2023	BUY	$10.62 - $17.34 $130,997 - $213,888	12,335 New	12,335 $136,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $23.43 $21,628 - $32,778	-1,399 Reduced 0.51%	270,907 $4.42 Million
Q2 2022 Aug 08, 2022	BUY	$11.18 - $20.5 $1.48 Million - $2.72 Million	132,671 Added 95.01%	272,306 $3.96 Million
Q1 2022 May 16, 2022	BUY	$14.2 - $23.78 $1.98 Million - $3.32 Million	139,635 New	139,635 $2.58 Million

256

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.25B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.